GlaxoSmithKline Plc (GSK):企業の財務・戦略的SWOT分析

◆英語タイトル:GlaxoSmithKline Plc (GSK) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH4279FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年3月
◆ページ数:101
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥28,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥42,750見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

GlaxoSmithKline Plc (GSK) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

GlaxoSmithKline Plc (GSK) is a healthcare company that focuses on the development, manufacture and commercialization of pharmaceuticals, vaccines and consumer healthcare products. It offers drugs for the treatment of HIV, respiratory, cancer, immuno-inflammation, anti-virals, central nervous system (CNS), metabolic, cardiovascular and urogenital, anti-bacterials, dermatology and rare diseases. The company also offers over-the-counter (OTC) products for pain relief, oral health, nutrition, skin health and gastro-intestinal diseases. GSK’s vaccine portfolio covers various diseases including hepatitis, diphtheria, tetanus, whooping cough, rotavirus and HPV infections, measles and bacterial meningitis among others. The company sells its products through wholesalers, pharmacies, hospitals, physicians and other groups worldwide. GSK is headquartered in Brentford, Middlesex, the UK.

GlaxoSmithKline Plc Key Recent Developments

Mar 19,2021: Boston Pharma signs out-licensing agreement with GSK
Mar 11,2021: GSK to expand clinical trial manufacturing capacity at CGT Catapult site in UK
Feb 18,2021: GSK, Vir expand collaboration for influenza, respiratory virus therapies
Feb 12,2021: Sandoz signs $500m deal to acquire GSK’s cephalosporin antibiotics business
Feb 04,2021: GSK and CureVac enter Covid-19 vaccine development collaboration

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
GlaxoSmithKline Plc – Key Facts
GlaxoSmithKline Plc – Key Employees
GlaxoSmithKline Plc – Key Employee Biographies
GlaxoSmithKline Plc – Major Products and Services
GlaxoSmithKline Plc – History
GlaxoSmithKline Plc – Company Statement
GlaxoSmithKline Plc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture
Section 2 – Company Analysis
Company Overview
GlaxoSmithKline Plc – Business Description
Business Segment: Consumer Healthcare
Overview
Performance
Key Stats
Business Segment: Pharmaceuticals
Overview
Performance
Key Stats
Business Segment: Vaccines
Overview
Performance
Key Stats
Geographical Segment: Rest of World
Performance
Geographical Segment: The UK
Performance
Geographical Segment: The US
Performance
R&D Overview
GlaxoSmithKline Plc – Corporate Strategy
GlaxoSmithKline Plc – SWOT Analysis
SWOT Analysis – Overview
GlaxoSmithKline Plc – Strengths
GlaxoSmithKline Plc – Weaknesses
GlaxoSmithKline Plc – Opportunities
GlaxoSmithKline Plc – Threats
GlaxoSmithKline Plc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
GlaxoSmithKline Plc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
GlaxoSmithKline Plc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
GlaxoSmithKline Plc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Mar 19, 2021: Boston Pharma signs out-licensing agreement with GSK
Mar 11, 2021: GSK to expand clinical trial manufacturing capacity at CGT Catapult site in UK
Feb 18, 2021: GSK, Vir expand collaboration for influenza, respiratory virus therapies
Feb 04, 2021: GSK and CureVac enter Covid-19 vaccine development collaboration
Feb 03, 2021: GSK delivers FY 2020 reported sales of £34 billion, +1% AER, +3% CER and Adjusted EPS of 115.9p, -6% AER, -4% CER, in line with guidance; Total EPS 115.5p, +23% AER
Jan 28, 2021: Lilly, Vir and GSK collaborate for trial of Covid-19 therapies
Jan 26, 2021: GSK ranks 1st in the 2021 Access to Medicine Index with leading R&D pipeline for priority diseases
Jan 22, 2021: Ten leading bioPharma companies announce formation of Accumulus Synergy to develop global data sharing platform
Jan 19, 2021: Novartis and GSK announce collaboration to support scientific research into genetic diversity in Africa
Jan 04, 2021: Philips and GSK partner to better inform parents about child vaccination
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
GlaxoSmithKline Plc, Key Facts
GlaxoSmithKline Plc, Key Employees
GlaxoSmithKline Plc, Key Employee Biographies
GlaxoSmithKline Plc, Major Products and Services
GlaxoSmithKline Plc, History
GlaxoSmithKline Plc, Other Locations
GlaxoSmithKline Plc, Subsidiaries
GlaxoSmithKline Plc, Joint Venture
GlaxoSmithKline Plc, Key Competitors
GlaxoSmithKline Plc, Ratios based on current share price
GlaxoSmithKline Plc, Annual Ratios
GlaxoSmithKline Plc, Annual Ratios (Cont...1)
GlaxoSmithKline Plc, Annual Ratios (Cont...2)
GlaxoSmithKline Plc, Interim Ratios
GlaxoSmithKline Plc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
GlaxoSmithKline Plc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
GlaxoSmithKline Plc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[GlaxoSmithKline Plc (GSK):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Intarcia Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Intarcia Therapeutics Inc (Intarcia), formerly BioMedicines Inc is a biopharmaceutical company that discovers, develops and commercializes drug therapies. The company’s product candidates include ITCA 650, used for the treatment of type II diabetes and obesity. It offers technology platform …
  • Illumina Inc (ILMN)-医療機器分野:企業M&A・提携分析
    Summary Illumina, Inc. (Illumina) provides genomic sequencing and array-based solutions for genetic analysis in the areas of molecular diagnostics, translational and consumer genomics, and oncology. The company’s portfolio encompasses sequencing tools and systems; sequencing kits and reagents; micro …
  • Noramco Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Noramco Inc (Noramco), a subsidiary of Johnson & Johnson is a manufacturer and distributor of bulk active ingredients. The company's products comprise amphetamine L aspartate, amphetamine sulfate, dextroamphetamine saccharate, dextroamphetamine sulfate, buprenorphine base, buprenorphine HCL, …
  • Odebrecht S.A.:戦略・SWOT・企業財務分析
    Odebrecht S.A. - Strategy, SWOT and Corporate Finance Report Summary Odebrecht S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • International Flavors & Fragrances Inc (IFF):企業の財務・戦略的SWOT分析
    International Flavors & Fragrances Inc (IFF) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key stren …
  • Claris Lifesciences Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Claris Lifesciences Ltd (Claris) is a manufacturer of generic drugs and pharmaceutical products. The company provides generic drugs that are directly injected into the human body, which is mainly used in the treatment of critical illnesses. It provides products are offered through various de …
  • Mitsui Mining & Smelting Co Ltd:企業の戦略・SWOT・財務分析
    Mitsui Mining & Smelting Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Mitsui Mining & Smelting Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Intercept Pharmaceuticals Inc (ICPT):製薬・医療:M&Aディール及び事業提携情報
    Summary Intercept Pharmaceuticals Inc (Intercept) is a biopharmaceutical company that researches, develops and commercializes treatments for non-viral, progressive liver diseases. It develops products using its proprietary bile acid chemistry. The company’s lead product candidate, obeticholic acid ( …
  • Viking Therapeutics Inc (VKTX):製薬・医療:M&Aディール及び事業提携情報
    Summary Viking Therapeutics Inc (Viking Therapeutics) is a clinical-stage biopharmaceutical company that develops novel therapies for patients suffering from metabolic and endocrine disorders. The company’s lead clinical program product candidate include VK5211, an orally available, non-steroidal se …
  • EpiVax Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary EpiVax Inc (EpiVax) develops analytical capabilities in the field of computational immunology. Its product pipeline includes Tregitopes; deimmunization projects including deimmunized botox and deimmunized FVIII; and biodefense vaccines. Tregitopes are linear sequences of amino acids which ac …
  • Bruce Power LP:企業の戦略的SWOT分析
    Bruce Power LP - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Venture Lighting International Inc:企業の戦略的SWOT分析
    Venture Lighting International Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Grupo Aval Acciones y Valores S.A.:戦略・SWOT・企業財務分析
    Grupo Aval Acciones y Valores S.A. - Strategy, SWOT and Corporate Finance Report Summary Grupo Aval Acciones y Valores S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Travis Perkins plc:企業の戦略・SWOT・財務分析
    Travis Perkins plc - Strategy, SWOT and Corporate Finance Report Summary Travis Perkins plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Sangoma Technologies Corporation (STC):企業の財務・戦略的SWOT分析
    Sangoma Technologies Corporation (STC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • Everist Genomics Inc-医療機器分野:企業M&A・提携分析
    Summary Everist Genomics Inc (Everest Health), formerly Genetics Squared Inc is a developer of prognostics, medical diagnostic and therapeutic selection technologies. The company provides angiodefender cardiovascular disease diagnostic system, a non invasive device that is used for combining sensor …
  • Sotera Wireless Inc:医療機器:M&Aディール及び事業提携情報
    Summary Sotera Wireless Inc (Sotera Wireless) is a medical device company that provides technology products. The company develops and markets vital signs monitoring systems, ViSi Mobile systems, mobile monitor systems, and others. Its ViSi Mobile System is a platform for comprehensive vital signs mo …
  • Schibsted ASA:企業のM&A・事業提携・投資動向
    Schibsted ASA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Schibsted ASA Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments …
  • NetScout Systems, Inc. (NTCT):企業の財務・戦略的SWOT分析
    NetScout Systems, Inc. (NTCT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Hitachi Construction Machinery Co., Ltd. (6305):企業の財務・戦略的SWOT分析
    Hitachi Construction Machinery Co., Ltd. (6305) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key st …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆